Mylan Pharmaceuticals: A Case Study

Great Essays
Mylan Pharmaceuticals has been in the spotlight lately, but not exactly in a positive way. The media and consumers have made it known that they don’t appreciate excessive price hikes in one of the many drugs Mylan produces. The EpiPen is designed for patients who have a severe allergic reaction to some substance or extreme cases of asthma attacks. Unfortunately for those that need the drug, prices have increased from $57 in 2007 to about $616 for a two-pack today—an increase of 1,080%. Just since 2013, price have risen from $249—that’s a 247% increase (USA Today). So why are these drug prices rising so quickly? Is there an ethical dilemma in play here that should be addressed, is this simply good business, or is there perhaps a legitimate reason for the dramatic price hikes? In this paper, I will be evaluating the pharmaceutical and insurance industries (specifically Mylan) to determine why prices have been increasing for …show more content…
Auvi-Q, an auto-injector epinephrine product now produced by Kaleo Pharmaceuticals (formerly produced by Sanofi) will be placed on the market sometime in 2017. They have yet to set a price, but most people believe they will only be a few dollars cheaper than the EpiPen (Arstechnica). It had previously been on the market but was taken off in 2015 over fears that the dosage was not correct in some units. Due to patent laws, a generic has yet to be developed, tested and sold until the patent expires in 2025 (NPR). It is not uncommon to see that drug prices elsewhere in the world are cheaper than the U.S. for various reasons. Some suggest Obamacare has driven those prices up as well, but I don’t believe it is Obamacare alone that causes a 247% increase since 2013. A similar version of the EpiPen is sold in France by another company for about $170 for a two-pack

Related Documents

  • Improved Essays

    Pharmaceutical companies usually only increase the price of the drug if a competition is found between companies, this is not the case. Some patients do not notice the drastic price increase due to insurance masking the cost. Mylan (EP) is not the only drug that has seen a drastic increase in prices over the past couple of years. After reading several articles it was found that Mylan could only increase the price due to no competition within the pharmaceutical marketplace. Over the past few years the price of the EP has gone up approximately 400% due to competition and increased drug prices.…

    • 1053 Words
    • 5 Pages
    Improved Essays
  • Superior Essays

    Americans use more prescription drugs than any other developed country. Prescription drugs only represent 12 percent of total health care costs in the United States, but the rising prices of those drugs is an issue that keeps reoccurring not only for patients, but for prescribers, payers, and policy makers. There are people that believe that the rise in price of these drugs is appropriate, but if they keep on rising in price, the United States will start suffering not only financially but medically. Despite a lot of other aspects of the economy rising in price, pharmaceutical drugs should be lowered, or should at least be kept at a reasonable rate. The rise in prices of prescription drugs is an issue that does not seem to be going away…

    • 2472 Words
    • 10 Pages
    Superior Essays
  • Improved Essays

    According to Shaw (2008), the majority of advertising expenditures fall within seven categories: heartburn; insomnia; cholesterol; asthma and allergy; nail fungus; depression; and erectile dysfunction. In turn, drugs used to treat these disorders are often among the best-selling drugs. The popularity of these drugs correlates to increased revenue for the pharmaceutical companies, which motivates more advertising, but not more research. Gagnon and Lexchin (2008) revealed pharmaceutical companies routinely spend twice the amount on marketing in the United States than developing new or safer drugs. The following table directly refutes the drug company’s assertions the…

    • 1366 Words
    • 5 Pages
    Improved Essays
  • Great Essays

    Gieringer’s studies state, “that revenues from cannabis excise taxes might range from $2.2 to $6.4 billion per year.” That tax estimate is from 1994 and does not even include other taxes, such as sin tax or sales tax, meaning the current value is probably much higher. Estimates show legal cannabis could become a $45 to $100 billion market, according to economist Stephen Easton in 2010 (Bradford). These profits would be very beneficial to the United States as the economy has been slowly degrading. On top of the large amount of jobs created and the economic earnings, legalization would also allow for hemp production. Hemp is a very useful material that was only prohibited because of its narcotic effects.…

    • 1751 Words
    • 7 Pages
    Great Essays
  • Improved Essays

    Introduction In recent news Turing Pharmaceuticals has been on the news for raising the price on their medicine at skyrocketing costs. One in particular, is a medicine known as Daraprim which cost only $13.50 per tablet, saw an increased on its cost overnight by $736.50 dollars per tablet after being bought by Turing Pharmaceuticals. Daraprim is used in curing a parasitic infection that can be life threatening if left untreated.Turing Pharmaceuticals has obtain other older medicines and increased their costs to a ridiculous price.This goes to show that human life in the United States is a business.The American people can barely afford full healthcare coverage as it is. Acquiring medical treatment to live should not be a luxury but a right.…

    • 1763 Words
    • 7 Pages
    Improved Essays
  • Great Essays

    As such, GlaxoSmithKline when formed was more assured of an income stream by patent protection as a singular drug didn’t account for greater than 12% of revenue and leading up to the merger only 7% of Glaxo Wellcome’s revenue came from drugs that had US patents expiring earlier than 2006 in contrast to SB’s 33%. II. The company has grown greatly in Central and Eastern Europe. Their share price had rocketed and associated costs to maintain and grow their presence in these markets such as marketing of new products were growing quickly as well. It was important for them to expand globally as a first-rate competitor cannot conduct all its operations from only their US home market that represented 6 to 8 per cent of its existence.…

    • 1125 Words
    • 5 Pages
    Great Essays
  • Superior Essays

    This was shocking to me because I was unaware that there was a preventative drug for HIV. I feel incorporating information of these drugs during discussion of safe sex could benefit the course as a whole. These medications are available to patients in industrialized countries and those in the developing world. In addition, this article also addressed that about a decade ago, disturbing $15,000 medications (which it would have cost) to individuals in developing countries looked impossible. Now, the number of people getting treatment in developing has been rising by about a million every year.…

    • 922 Words
    • 4 Pages
    Superior Essays
  • Improved Essays

    Merck & Co spent more than 160 million in 2000 for their pain reliever called Vioxx on advertising the drug, which gained the approval from FDA. However, they later found out that their drug could possibly raise the risk of heart attacks, the company chose to ignore it at first but pulled it from the market later, critics criticized consumer advertising for this incident, in 2007, similar drugs have warnings about heart and other possible side effects. To be more specific, the pharmaceutical industry spent nearly 29 billion for advertising alone, which is more than any other in-person sales pitches. FDA released a policy that was cracking down any false and misleading information in advertising for medicine, which successfully reduced advertising by almost 10 percent the following…

    • 788 Words
    • 4 Pages
    Improved Essays
  • Great Essays

    This is true in illegal narcotics because customers want to feel a difference in mental state, so a placebo is easily spotted.15 However, a placebo is not so easily spotted when it is given to a patient because the lack of therapeutic effect may not be noticed for months. By the time it is noticed, it could be difficult to trace the lack of effect to the counterfeit. In addition, some counterfeits contain small amounts of the active ingredient which is enough to relieve some symptoms, but not cure the…

    • 1642 Words
    • 7 Pages
    Great Essays
  • Improved Essays

    Medicine Information: The truth about Brand-Name vs. Generic Medicine Lately, there has been a lot of debate regarding the use of generic medicines versus brand names. Are generics truly as effective as brand-name drugs? It pays to be educated since, as per the FDA, "practically 8 in 10 prescriptions filled in the United States are for generic medicines. The use of generic medicines is expected to increase over the next couple of years as various popular brand-name drugs fall off patent through 2015." What is the difference between brand-name and generics?…

    • 826 Words
    • 4 Pages
    Improved Essays